English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52678156    線上人數 :  863
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yeh h i"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 131-155 / 210 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-03-05T06:05:29Z A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.
臺大學術典藏 2020-03-04T09:03:24Z Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet Lin L.-C.;Chau-Chung Wu;Yeh H.-I.;Lu L.-S.;Liu Y.-B.;Lin S.-F.;Lee Y.-T.; Lin L.-C.; CHAU-CHUNG WU; Yeh H.-I.; Lu L.-S.; Liu Y.-B.; Lin S.-F.; Lee Y.-T.
臺大學術典藏 2020-03-04T09:03:19Z Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.Y.I.; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K.; Liu Y.B.; Huang H.C.; Yang Y.F.; Lin L.C.; Lin L.Y.; CHAU-CHUNG WU
臺大學術典藏 2020-03-04T09:03:11Z Gender difference in statin intervention on blood lipid control among patients with coronary heart disease Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:10Z Gender disparities in optimal lipid control among patients with coronary artery disease Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:09Z The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:08Z Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:07Z Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:07Z Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
臺大學術典藏 2020-03-04T09:03:06Z 2017 Taiwan lipid guidelines for high risk patients Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients
臺大學術典藏 2020-03-04T09:03:06Z Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:05Z Optimal achieved blood pressure for patients with stable coronary artery disease Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:05Z Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
臺大學術典藏 2020-03-04T09:03:05Z Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:04Z Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU
臺大學術典藏 2020-03-04T09:03:03Z The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:03Z Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013) Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients
臺大學術典藏 2020-03-04T09:03:03Z On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
臺大學術典藏 2020-03-04T09:03:02Z A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.
臺大學術典藏 2020-03-04T09:03:02Z Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W.
臺大學術典藏 2020-03-04T09:03:02Z The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU
臺大學術典藏 2020-03-04T09:03:00Z The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R.
臺大學術典藏 2020-03-04T09:03:00Z Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x) Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W.
臺大學術典藏 2020-03-04T05:42:45Z 2017 Taiwan lipid guidelines for high risk patients The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I
臺大學術典藏 2020-03-04T05:42:38Z Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013) Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients

顯示項目 131-155 / 210 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目